3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow 17-alpha-Hydroxyprogesterone: new trials by email Literature Review of 17-alpha-Hydroxyprogesterone trials Research Report on 17-alpha-Hydroxyprogesterone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Improving Pregnancy Outcomes With Progesterone 17P, Placebo - Pre-term Birth, HIV-1-infection | Phase 3 | Completed | University of North Carolina, Chapel Hill | 800 | 2018-02-07 | 2021-07-22 |
| Progestagens for the Tertiary Prophylaxis of Preterm Delivery 17 alpha-hydroxy progesterone caproate, micronized Progesterone, Control - Preterm Delivery, Neonatal Complications | Phase 3 | Completed | University of Modena and Reggio Emilia | 254 | 2010-02-01 | 2016-09-23 |
| Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in High Risk Pregnancies 17 alpha-Hydroxyprogesterone Caproate and Omega-3 supplement, 17 alpha-hydroxy progesterone caproate and Placebo supplement - Preterm Birth | Phase 3 | Completed | The George Washington University Biostatistics Center | 800 | 2005-02-01 | 2019-07-12 |
Premature Birth (3)
The George Washington University Biostatistics Center (1) · University of Modena and Reggio Emilia (1) · University of North Carolina, Chapel Hill (1)
Italy (1) · United States (1) · Zambia (1)
Elizabeth A Thom, PhD (1) · Fabio Facchinetti, M.D. (1) · Jeff Stringer, MD, FACOG (1) · Margaret Harper, MD (1) · Menachem Miodovnik, MD (1)
PMID 20093894, PMID 21173653, PMID 21508745, PMID 23635681, PMID 28594783, PMID 30813934, PMID 34509197
2009 (1), R01HD087119 (1), U10HD021410 (1), U10HD027860 (1), U10HD027869 (1), U10HD027915 (1), U10HD027917 (1), U10HD034136 (1), U10HD034208 (1), U10HD036801 (1), U10HD040485 (1), U10HD040500 (1), U10HD040512 (1), U10HD040544 (1), U10HD040545 (1)